新型超低容量方案联合1升聚乙二醇与利那洛肽对比2升聚乙二醇在低风险个体结肠镜检查肠道准备中的随机对照试验
这项前瞻性、随机、观察者盲法、多中心研究纳入548例低风险结肠镜检查患者,比较1升聚乙二醇联合利那洛肽方案与单剂2升聚乙二醇方案的肠道清洁效果与耐受性。结果显示1升方案在肠道清洁充分性上非劣于2升方案,且恶心、呕吐更少,重复准备意愿更高。
要点
- 1升聚乙二醇联合利那洛肽方案肠道清洁充分性非劣于2升聚乙二醇方案。
- 1升方案组恶心(7.7% vs 17.1%)和呕吐(4.0% vs 10.9%)发生率更低。
- 1升方案组重复肠道准备意愿更高(95.2% vs 82.2%)。
核心结论
- 在低风险人群中,1升聚乙二醇联合利那洛肽方案在结肠清洁方面非劣于2升聚乙二醇方案,且耐受性更好、重复肠道准备意愿更高。
研究设计与样本
- 前瞻性、随机、观察者盲法、多中心研究,低风险成人结肠镜检查患者按1:1随机接受1升聚乙二醇联合利那洛肽方案或2升聚乙二醇方案。
- 全分析集548例,符合方案集522例。
主要发现
- 肠道清洁充分性:全分析集中1升方案组90.5% vs 2升方案组91.6%(P = .644),符合方案集中1升方案组90.3% vs 2升方案组92.4%(P = .390),非劣效成立。
- 波士顿肠道准备量表总分及各段评分、盲肠插管率、盲肠插入时间、退镜时间、息肉检出率、腺瘤检出率组间均无显著差异(均P > .05)。
- 1升方案组恶心发生率7.7% vs 2升方案组17.1%(P < .01),呕吐发生率4.0% vs 10.9%(P < .01),重复肠道准备意愿95.2% vs 82.2%(P < .01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The single dose of 2 L polyethylene glycol (PEG) has shown high cleaning efficacy and tolerability in low-risk patients. However, the dosage of this regimen is still challenging for many patients. We investigated the efficacy and tolerability of a novel ultra-low-volume regimen using 1 L PEG and linaclotide (1 L PEG+L) versus a single dose of 2 L PEG in low-risk patients. METHODS: In this prospective, randomized, observer-blinded, multicenter study, low-risk adult patients scheduled for colonoscopy were enrolled and randomized (1:1) to receive the 1 L PEG+L regimen or the 2 L PEG regimen. The primary outcome was the effectiveness of bowel cleansing according to the Boston Bowel Preparation Scale. Secondary outcomes included cecal intubation rate, cecal insertion time, withdrawal time, polyp detection rate and adenoma detection rate, tolerability, adverse events, and willingness to repeat bowel preparation. The full analysis set (FAS) and per-protocol set (PPS) were used for statistical analyses. RESULTS: A total of 548 patients comprised the FAS, and 522 patients comprised the PPS. Noninferiority on adequate bowel cleansing of 1 L PEG+L vs 2 L PEG was established both in FAS (90.5% vs 91.6%, P = .644) and PPS (90.3% vs 92.4%, P = .390). There were no significant differences regarding the total score and each segment scores of the Boston Bowel Preparation Scale, cecal intubation rate, cecal insertion time, withdrawal time, polyp detection rate, and adenoma detection rate (all, P > .05). However, patients in the 1 L PEG+L group reported less nausea (7.7% vs 17.1%, P < .01) and vomiting (4.0% vs 10.9%, P < .01) and had a higher willingness to repeat bowel preparation (95.2% vs 82.2%, P < .01). CONCLUSIONS: The regimen of 1 L PEG+L was not inferior to 2 L PEG on colon cleansing, with better tolerability and higher willingness to repeat the bowel preparation in a low-risk population. (Clinical trial registration number: ChiCTR2100053273.).
引用
- Zhang C, Chen X, Tang B, et al. A novel ultra-low-volume regimen combining 1 L polyethylene glycol and linaclotide versus 2 L polyethylene glycol for colonoscopy cleansing in low-risk individuals: a randomized controlled trial. Gastrointest Endosc. 2022. PMID: 36572127. doi:10.1016/j.gie.2022.12.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。